Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;236(4):3059-3072.
doi: 10.1002/jcp.30069. Epub 2020 Sep 23.

Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB

Affiliations

Angiotensin-(1-7) prevents T3-induced cardiomyocyte hypertrophy by upregulating FOXO3/SOD1/catalase and downregulating NF-ĸB

Nathalia Senger et al. J Cell Physiol. 2021 Apr.

Abstract

Clinical studies have shown a correlation between thyroid disorders and cardiac diseases. High levels of triiodothyronine (T3) induce cardiac hypertrophy, a risk factor for cardiac complications and heart failure. Previous results have demonstrated that angiotensin-(1-7) is able to block T3-induced cardiac hypertrophy; however, the molecular mechanisms involved in this event have not been fully elucidated. Here, we evidenced the contribution of FOXO3 signaling to angiotensin-(1-7) effects. Angiotensin-(1-7) treatment increased nuclear FOXO3 levels and reduced p-FOXO3 levels (inactive form) in isolated cardiomyocytes. Knockdown of FOXO3 by RNA silencing abrogated the antihypertrophic effect of angiotensin-(1-7). Increased expression of antioxidant enzymes superoxide dismutase 1 (SOD1 and catalase) and lower levels of reactive oxygen species and nuclear factor-κB (NF-κB) were observed after angiotensin-(1-7) treatment in vitro. Consistent with these results, transgenic rats overexpressing angiotensin-(1-7) displayed increased nuclear FOXO3 and SOD1 levels and reduced NF-κB levels in the heart. These results provide a new molecular mechanism responsible for the antihypertrophic effect of angiotensin-(1-7), which may contribute to future therapeutic targets.

Keywords: FOXO3; SOD; angiotensin-(1-7); cardiomyocyte hypertrophy; catalase; thyroid hormone.

PubMed Disclaimer

References

REFERENCES

    1. Almeida, P. W., Melo, M. B., Lima, R. F., Gavioli, M., Santiago, N. M., Greco, L., & Guatmosin, S. (2015). Beneficial effects of angiotensin-(1-7) against deoxycorticosterone acetate-induced diastolic dysfunction occur independently of changes in blood pressure. Hypertension, 66(2), 389-395. https://doi.org/10.1161/HYPERTENSIONAHA.114.04893
    1. Araujo, A. S., Diniz, G. P., Seibel, F. E., Branchini, G., Ribeiro, M. F., Brum, I. S., & Belló-Klein, A. (2011). Reactive oxygen and nitrogen species balance in the determination of thyroid hormones-induced cardiac hypertrophy mediated by renin-angiotensin system. Journal of Molecular Endocrinology, 333(1), 78-84. https://doi.org/10.1016/j.mce.2010.12.018
    1. Araujo, A. S., Schenkel, P., Enzveiler, A. T., Fernandes, T. R., Partata, W. A., Llesuy, S., & Belló-Klein, A. (2008). The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. Journal of Molecular Endocrinology, 41(6), 423-430. https://doi.org/10.1677/JME-08-0024
    1. Asayama, K., Dobachi, K., Hayashibe, H., Megata, Y., & Kato, K. (1987). Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: A possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology, 121(6), 2112-2118. https://doi.org/10.1210/endo-121-6-2112
    1. Barreto-Chaves, M. L. M., Heimann, A., & Krieger, J. E. (2000). Stimulatory effects of dexamethasone on angiotensin-converting enzyme in neonatal rat cardiac myocytes. Brazilian Journal of Medical and Biological Research, 33(6), 661-664. https://doi.org/10.1590/s0100-879x2000000600007

Publication types

MeSH terms

LinkOut - more resources